(Q52136489)

22 April 2018

title

Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). (English)

1 reference

22 April 2018

main subject

aggressive fibromatosis

1 reference

8

1 reference

22 April 2018

author name string

Poon R

1

1 reference

22 April 2018

Smits R

2

1 reference

22 April 2018

Li C

3

1 reference

22 April 2018

Jagmohan-Changur S

4

1 reference

22 April 2018

Kong M

5

1 reference

22 April 2018

Cheon S

6

1 reference

22 April 2018

Yu C

7

1 reference

22 April 2018

Alman BA

9

1 reference

22 April 2018

language of work or name

English

0 references

publication date

1 January 2001

1 reference

22 April 2018

published in

Oncogene

1 reference

22 April 2018

volume

20

1 reference

22 April 2018

issue

4

1 reference

22 April 2018

page(s)

451-460

1 reference

22 April 2018

The mechanisms of action of nonsteroidal antiinflammatory drugs

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

A selective inhibitor of cyclooxygenase-2 reverses endotoxin-induced pyretic responses in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Identification and characterization of the familial adenomatous polyposis coli gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Identification of FAP locus genes from chromosome 5q21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Noncytotoxic drug therapy in children with unresectable desmoid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

In vitro evaluation of antiproliferative potential of topical cyclooxygenase inhibitors in human Tenon's fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

The desmoid tumor. Not a benign disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

TCF transcription factors: molecular switches in carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

The genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Aspirin use and potential mechanisms for colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Characterization of arachidonic acid-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204107

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204107

1 reference

22 April 2018

1 reference

22 April 2018